nach oben

Erschienen in:

29.09.2023 | Global Health Services Research

The Impact and Opportunity of Inclusive Excellence: Addressing Social Determinants of Health in Cancer Clinical Trials

verfasst von: Selwyn M. Vickers, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 13/2023

Einloggen, um Zugang zu erhalten

Auszug

Martin Luther King is quoted to have said, “Of all the forms of inequality, injustice in health care is the most shocking and inhumane.” Health disparities are a clear challenge to the United States of America, both nationally and globally. Disparities in healthcare and health outcomes occur when those outcomes are largely driven by racial or ethnic differences and not due to access-related factors, clinical needs, or appropriateness of intervention.¹ Differences between populations and the presence of disease and health outcomes are well documented in the United States. These disparities primarily exist in minorities groups, including African Americans, Native Americans, Hispanic Americans, and Asian Americans. These groups have higher incidence of chronic disease, mortality, and poor overall health outcomes.² …

In: Smedley BD, Stith AY, Nelson AR, editors. Unequal treatment: confronting racial and ethnic disparities in health care. 2003.

KFF. Key data on health and health care by race and ethnicity. Kaiser Family Foundation. https://www.kff.org/racial-equity-and-health-policy/report/key-data-on-health-and-health-care-by-race-and-ethnicity/.

Hammonds EM, Reverby SM. Toward a historically informed analysis of racial health disparities since 1619. Am J Public Health. 2019;109(10):1348–9. https://doi.org/10.2105/AJPH.2019.305262.CrossRefPubMedPubMedCentral

National Cancer Institute. Cancer disparities. Accessed 15 Mar 2023. https://www.cancer.gov/about-cancer/understanding/disparities.

American Association of Cancer Research. State of cancer health disparities 2020. Cancer progress report. Accessed 15 Mar 2023. https://cancerprogressreport.aacr.org/disparities/chd20-contents/chd20-state-of-cancer-health-disparities-2020/.

Silver GA. The infamous Tuskegee study. Am J Public Health. 1988;78(11):1500. https://doi.org/10.2105/ajph.78.11.1500.CrossRefPubMedPubMedCentral

Rodriguez MA, Garcia R. First, do no harm: the US sexually transmitted disease experiments in Guatemala. Am J Public Health. 2013;103(12):2122–6. https://doi.org/10.2105/AJPH.2013.301520.CrossRefPubMedPubMedCentral

Sterling RL. Genetic research among the Havasupai—a cautionary tale. Virtual Mentor. 2011;13(2):113–7. https://doi.org/10.1001/virtualmentor.2011.13.2.hlaw1-1102.CrossRefPubMed

Lacks H. science must right a historical wrong. Nature. 2020;585(7823):7. https://doi.org/10.1038/d41586-020-02494-z.CrossRef

10.

Scoggins JF, Ramsey SD. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. J Natl Cancer Inst. 2010;102(17):1371. https://doi.org/10.1093/jnci/djq291.CrossRefPubMedPubMedCentral

11.

Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291(22):2720–6. https://doi.org/10.1001/jama.291.22.2720.CrossRefPubMed

12.

Robinson JM, Trochim WM. An examination of community members’, researchers’ and health professionals’ perceptions of barriers to minority participation in medical research: an application of concept mapping. Ethn Health. 2007;12(5):521–39. https://doi.org/10.1080/13557850701616987.CrossRefPubMed

13.

Snyder RA, Chang GJ. Insurance status as a surrogate for social determinants of health in cancer clinical trials. JAMA Netw Open. 2020;3(4):e203890. https://doi.org/10.1001/jamanetworkopen.2020.3890.CrossRefPubMed

14.

Asare M, Flannery M, Kamen C. Social determinants of health: a framework for studying cancer health disparities and minority participation in research. Oncol Nurs Forum. 2017;44(1):20–3. https://doi.org/10.1188/17.ONF.20-23.CrossRefPubMedPubMedCentral

15.

Minnesota Department of Health. Advancing Health equity in Minnesota: report to the legislature. 2014.

16.

U.S. Department of Health and Human Services. Social Determinants of Health. Accessed 12 Mar 2023. https://health.gov/healthypeople/priority-areas/social-determinants-health.

17.

Artiga S, Hinton, E. Beyond health care: the role of social determinants in promoting health and health equity. KFF. Accessed 15 Mar 2023. https://www.kff.org/racial-equity-and-health-policy/issue-brief/beyond-health-care-the-role-of-social-determinants-in-promoting-health-and-health-equity/.

18.

U.S. Census Bureau. 2020 Census statistics highlight local population changes and Nation’s racial and ethnic diversity. census.gov. Accessed 15 Mar 2023. https://www.census.gov/newsroom/press-releases/2021/population-changes-nations-diversity.html.

19.

Surveillance, Epidemiology, and End Results (SEER) Program. Cancer stat facts: cancer disparities. National Cancer Institute. Accessed 18 Mar 2023. https://seer.cancer.gov/statfacts/html/disparities.html.

20.

Vickers SM, Fouad MN. An overview of EMPaCT and fundamental issues affecting minority participation in cancer clinical trials: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual. Cancer. 2014;120(Suppl 7):1087–90. https://doi.org/10.1002/cncr.28569.CrossRefPubMed

21.

Fouad MN, Acemgil A, Bae S, et al. Patient navigation as a model to increase participation of African Americans in cancer clinical trials. J Oncol Pract. 2016;12(6):556–63. https://doi.org/10.1200/JOP.2015.008946.CrossRefPubMedPubMedCentral

22.

Ramsey BW, Nepom GT, Lonial S. Academic, foundation, and industry collaboration in finding new therapies. N Engl J Med. 2017;376(18):1762–9. https://doi.org/10.1056/NEJMra1612575.CrossRefPubMedPubMedCentral

23.

Gany F, Melnic I, Wu M, et al. Food to overcome outcomes disparities: a randomized controlled trial of food insecurity interventions to improve cancer outcomes. J Clin Oncol. 2022;40(31):3603–12. https://doi.org/10.1200/JCO.21.02400.CrossRefPubMedPubMedCentral

24.

Alatise OI, Knapp GC, Bebington B, et al. Racial differences in the phenotype of colorectal cancer: a prospective comparison between Nigeria and South Africa. World J Surg. 2022;46(1):47–53. https://doi.org/10.1007/s00268-021-06304-z.CrossRefPubMed

25.

Li BT, Daly B, Gospodarowicz M, et al. Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition. Nat Med. 2022;28(4):620–6. https://doi.org/10.1038/s41591-022-01775-6.CrossRefPubMed

26.

Flaherty KT, Gray R, Chen A, et al. The molecular analysis for therapy choice (NCI-MATCH) trial: lessons for genomic trial design. J Natl Cancer Inst. 2020;112(10):1021–9. https://doi.org/10.1093/jnci/djz245.CrossRefPubMedPubMedCentral

27.

Vanguri RS, Luo J, Aukerman AT, et al. Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer. Nat Cancer. 2022;3(10):1151–64. https://doi.org/10.1038/s43018-022-00416-8.CrossRefPubMedPubMedCentral

Titel: The Impact and Opportunity of Inclusive Excellence: Addressing Social Determinants of Health in Cancer Clinical Trials
verfasst von: Selwyn M. Vickers, MD
Publikationsdatum: 29.09.2023
Verlag: Springer International Publishing
Erschienen in: Annals of Surgical Oncology / Ausgabe 13/2023
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-023-14288-4

ASO Visual Abstract: Growing Deficit in New Cancer Diagnoses 2 Years into the COVID-19 Pandemic—A National Multicenter Study

ASO Visual Abstract

ASO Visual Abstract: Transferrin Receptor is Associated with Sensitivity to Ferroptosis Inducers in Hepatocellular Carcinoma

ASO Visual Abstract

ASO Visual Abstract: Granzyme B (GZMB)-Positive Tumor-Infiltrating Lymphocytes in Lung Adenocarcinoma: Significance as a Prognostic Factor and Association With Immunosuppressive Proteins

ASO Visual Abstract

ASO Visual Abstract: Mutational Status is Associated with Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer

ASO Visual Abstract

Distribution and Rate of Myxoid Liposarcoma Spine Metastases: Impact on Surveillance Imaging

Sarcoma

Clinical Impact of Radical Resection of Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer

Colorectal Cancer

Neu im Fachgebiet Chirurgie

Lohnt sich die Karotis-Revaskularisation?

25.04.2025
Karotisstenose
Nachrichten

Die medikamentöse Therapie für Menschen mit Karotisstenosen hat sich in den vergangenen Dekaden verbessert. Braucht es also noch einen invasiven Eingriff zur Revaskularisation der Halsschlagader bei geringem bis moderatem Risiko für einen ipsilateralen Schlaganfall?

Höhere Dosis von Dexamethason senkt Überlebenschancen

25.04.2025
Zerebrale Metastasen
Nachrichten

Personen mit Hirnmetastasen, die perioperativ höhere kumulative Dosen von Dexamethason erhalten, haben eine schlechtere Prognose. Um die Ergebnisse zu verbessern, bedarf es strengerer Dosierungsschemata.

Appendektomie erhält Remission bei Colitis ulcerosa

24.04.2025
Colitis ulcerosa
Nachrichten

Wird der Wurmfortsatz bei Personen mit Colitis ulcerosa entfernt, ist die Rückfallrate um ein Drittel geringer als unter konservativer Behandlung. Auch die Lebensqualität verbessert sich und der Bedarf an Medikamenten nimmt ab.

Op.-Entscheidung bei Divertikulitis: Lebensqualität zählt!

22.04.2025
Divertikulitis
Nachrichten

Soll man Menschen, die schon mehrfach schmerzhafte Divertikulitisepisoden durchgemacht haben, eine Op. anbieten? Ein Team aus Helsinki rät, dies von der Lebensqualität abhängig zu machen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The Impact and Opportunity of Inclusive Excellence: Addressing Social Determinants of Health in Cancer Clinical Trials

Auszug

Weitere Artikel der Ausgabe 13/2023

ASO Visual Abstract: Growing Deficit in New Cancer Diagnoses 2 Years into the COVID-19 Pandemic—A National Multicenter Study

ASO Visual Abstract: Transferrin Receptor is Associated with Sensitivity to Ferroptosis Inducers in Hepatocellular Carcinoma

ASO Visual Abstract: Granzyme B (GZMB)-Positive Tumor-Infiltrating Lymphocytes in Lung Adenocarcinoma: Significance as a Prognostic Factor and Association With Immunosuppressive Proteins

ASO Visual Abstract: Mutational Status is Associated with Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer

Distribution and Rate of Myxoid Liposarcoma Spine Metastases: Impact on Surveillance Imaging

Clinical Impact of Radical Resection of Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer

Neu im Fachgebiet Chirurgie

Lohnt sich die Karotis-Revaskularisation?

Höhere Dosis von Dexamethason senkt Überlebenschancen

Appendektomie erhält Remission bei Colitis ulcerosa

Op.-Entscheidung bei Divertikulitis: Lebensqualität zählt!

Update Chirurgie

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten